Literature DB >> 15884191

Quantifying quality of life for economic analysis: time out for time tradeoff.

T M Arnesen1, O F Norheim.   

Abstract

The "Time trade-off" (TTO), is the most widely used method to "quality adjust" life years for "QALYs" in cost utility analysis. In this paper we ask if it is theoretically likely that the TTO is valid for this use. The TTO consists in a trade off between longevity and quality of life. Firstly, we argue that it is impossible to control for all factors that may influence one's willingness to sacrifice lifetime. Secondly, that longevity and quality of life are too closely interrelated for the hypothetical trade off to reveal real preferences. Thirdly, that the TTO handles the value of a life year inconsistently because it simultaneously assumes that it changes (as an outcome measure) and that it doesn't change (as a currency unit). Lastly, we ask whether the difficulties stem from an inherent contradiction in trying to quantify quality of life. The problems theoretical validity an internal consistency, contrast the use of the results as exact measurements. We conclude that cost utility analysis based on TTO cannot be trusted as a tool for setting priorities in health.

Keywords:  Health Care and Public Health

Mesh:

Year:  2003        PMID: 15884191     DOI: 10.1136/mh.29.2.81

Source DB:  PubMed          Journal:  Med Humanit        ISSN: 1468-215X


  6 in total

1.  QALYs: are they helpful to decision makers?

Authors:  Maurice McGregor; J Jaime Caro
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  An ethical analysis of international health priority-setting.

Authors:  Nuala Kenny; Christine Joffres
Journal:  Health Care Anal       Date:  2007-08-15

3.  Utility elicitation study in the UK general public for late-stage chronic lymphocytic leukaemia.

Authors:  Keith Tolley; Catherine Goad; Yunni Yi; Penny Maroudas; Amin Haiderali; Gwilym Thompson
Journal:  Eur J Health Econ       Date:  2012-09-01

4.  Elicitation of health state utilities associated with varying severities of flares in Systemic Lupus Erythematosus.

Authors:  C Pollard; S Hartz; S Liu Leage; M A Paget; J Cook; A Enstone
Journal:  Health Qual Life Outcomes       Date:  2015-05-28       Impact factor: 3.186

5.  Time trade-off: one methodology, different methods.

Authors:  Arthur E Attema; Yvette Edelaar-Peeters; Matthijs M Versteegh; Elly A Stolk
Journal:  Eur J Health Econ       Date:  2013-07

6.  Utility estimation for neurogenic bowel dysfunction in the general population.

Authors:  Kirsten L Simmons; Leah G Davis; Jonathan C Routh; Maryellen S Kelly
Journal:  J Pediatr Urol       Date:  2021-01-30       Impact factor: 1.921

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.